Long Corridor Asset Management LTD Cullinan Oncology, Inc. Transaction History
Long Corridor Asset Management LTD
- $115 Million
- Q4 2024
A detailed history of Long Corridor Asset Management LTD transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 15,000 shares of CGEM stock, worth $121,350. This represents 0.16% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$121,350
Previous $251,000
27.49%
% of portfolio
0.16%
Previous 0.29%
Shares
1 transactions
Others Institutions Holding CGEM
# of Institutions
152Shares Held
66.9MCall Options Held
41.1KPut Options Held
112K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$61.9 Million13.93% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$46.5 Million2.62% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$28.7 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$27.6 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$27.3 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $369M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...